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Abstract: 
Nasopharyngeal carcinoma in children is rare accounting for only 1% of all pediatric 
malignancies. Both genetic and environmental factors contribute to the development of 
nasopharyngeal carcinoma. In children there is a higher rate of undifferentiated histology. 
The mean age of diagnosis of nasopharyngeal carcinoma is 11 years old age and the most 
common site is nasopharynx. Palpable lymphadenopathy, dysphasia and neural defect are 
common associated signs. 
Our patient is a 15 years old boy who had a mass that located near by the heart in the left 
side of mediastinum with invasion to anterior mediastan from two years ago. In serial CT 
scans he had not evidence of nasopharyngeal involvement. In biopsy, nasopharyngeal 
carcinoma, non-keratinizing type, was diagnosed. Patient was treated by radiotherapy with 
54 GY and chemotherapy with taxotere. But the mass had not regression. Then, the patient 
was treated with cisplatine, 5-fluracil and folinic acid for total 3 cycle and after remission 
interferon beta was added to treatment for 6 months duration as a maintenance therapy. In 
1 year follow up the patient was in complete remission. in the course  of therapy , only 
hypothyroidism was occurred.  
Ectopic nasopharyngeal carcinoma in child hood, without nasopharyngeal involvement, 
initially can be detected in other sites such as pericardium. Also better results could be 
respected by neoadjuant chemotherapy based on cisplatine, 5-fluracil and 6 months 
interferon beta as a maintenance therapy before radiotherapy in child hood aggressive 
nasopharyngeal carcinoma. 
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